Capstone Therapeutics (OTCQB:CAPS) (“the Company”) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), announced today the initiation of dosing for its AEM-28 (Apo E mimetic peptide) Phase 1 human clinical trial in LDL/non-HDL cholesterol reduction.Continue reading
HTG Molecular Diagnostics and OvaGene Oncology Partner on Gynecologic Cancer Tests
TUCSON, AZ–(Marketwired – Apr 7, 2014) – HTG Molecular Diagnostics, Inc., (HTG) and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.Continue reading
Next Steps Announced in Advancing the ‘Arizona Biomedical Corridor’
Mayor Stanton and the Phoenix City Council Take Next Steps to Advance ‘Arizona Biomedical Corridor’
- Authorize $180 Million in Revenue Bonds to Finance Mayo Clinic’s Cutting-Edge Cancer Therapy Center
- Renew Agreement with ASU, Mayo Clinic to Develop Corridor
- State Land Dept. Will Auction Corridor Land by Year’s End
Biodesign Team using tobacco to thwart West Nile virus
An international research group, led by Arizona State University professor Qiang “Shawn” Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.Continue reading
TGen-led study discovers genetic cause of rare type of ovarian cancer
Scientific breakthrough could lead to new cancer treatments; study inspired by memory of 22-year-old patientContinue reading
TGen study identifies gene fusion as likely cause of rare type of thyroid cancer
Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading
SynCardia Total Artificial Heart Could Become the Life-Saving Answer to Heart Transplant Graft Failure
SynCardia Systems, Inc. Continues to Make Progress for Approval of the SynCardia Heart for Permanent Use to Save Patients Who Are Unlikely to Receive Another Donor HeartContinue reading
TGen-led study spotlights dog DNA role in developing new therapies for human cancers
Study shows timeframe for canine sample analysis fits clinical window for human medical advancementsContinue reading
UA Study of HIV-Related Lung Diseases to Help Understanding of Pulmonary Immunity and Vaccine Responses
Dr. Kenneth S. Knox and his UA College of Medicine – Tucson research team aim to understand the causes of HIV-associated chronic obstructive pulmonary disease (COPD), pulmonary hypertension and immune reconstitution inflammatory syndrome (IRIS), funded by a grant from the National Heart, Lung, and Blood Institute.Continue reading
TGen identifies key protein that helps prevent lung cancer tumors from being destroyed
By eliminating Mcl-1, radiation and chemotherapies could be more effective in treating the most common and deadly of all cancersContinue reading